Niva Thyroid NDC 75834-315

NDC codes

FDA NDC Directory

Product NDC (as listed)75834-315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75834-0315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75834-315-01	75834031501	100 TABLET in 1 BOTTLE (75834-315-01)Marketed from Jul 24, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Niva Thyroid
Generic name (nonproprietary): thyroid, porcine
Active ingredients: Thyroid — 180 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Nivagen Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jul 24, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 75834-315_1cce3de8-0aa9-4f05-9104-a84b7d91dd68SPL ID 1cce3de8-0aa9-4f05-9104-a84b7d91dd68SPL set ID eae7789a-d85d-4b04-a680-e688a371ebeeRxCUI 198278, 208545, 313385, 313387, 313391, 313393, 314267, 315235, 2642816, 2642818, 2642820, 2642822, 2642824, 2642826, 2642828, 2642830UNII 6RV024OAUQUPC 0375834316017, 0375834312019, 0375834313016, 0375834314013, 0375834317014, 0375834315010, 0375834310015, 0375834311012

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475834031501 followed by a unit qualifier and the quantity

Package 75834-0315-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 2, 2023.

Indications (excerpt from the label)

INDICATIONS & USAGE Niva Thyroid tablets are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). 2. As pituitary…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)